Arcutis Biotherapeutics, Inc. (ARQT) Financials

ARQT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 460.0 million 270.4 million
Dec. 31, 2025 433.0 million 243.5 million
Sept. 30, 2025 371.0 million 212.9 million
June 30, 2025 352.4 million 213.5 million

ARQT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 2.2 million 10.7 million
Dec. 31, 2025 26.2 million 10.1 million
Sept. 30, 2025 -1.8 million 10.0 million
June 30, 2025 246000 10.5 million

ARQT Net Income

No data available :(

ARQT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 224.0 million 5.3 million -
Dec. 31, 2025 221.0 million 5.3 million 5.3 million
Sept. 30, 2025 191.1 million 107.5 million 5.3 million
June 30, 2025 191.1 million 107.0 million 2.1 million

ARQT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 129.4 million
Dec. 31, 2025 135.6 million
Sept. 30, 2025 132.9 million
June 30, 2025 127.0 million

ARQT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 30.6 million 74.1 million -
Dec. 31, 2025 - 20.5 million 79.0 million -
Sept. 30, 2025 - 19.6 million 62.4 million -
June 30, 2025 78000 19.5 million 69.2 million -

ARQT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 105.4 million 9.8 million
Dec. 31, 2025 129.5 million 11.7 million
Sept. 30, 2025 99.2 million 8.7 million
June 30, 2025 81.5 million 7.5 million

ARQT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

ARQT

Price: $25.61

52 week price:
12.72
31.77

Earnings Per Share: -0.02 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 827862

Market Capitalization: 2.7 billion

Links: